CAPTOPRIL EG 50 mg, tablet quadrisectable 30 tablets
Active ingredients: Captopril
Commercialized according to BDPMDispensing in France: Prescription only
Tablet quadrisectable30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CAPTOPRIL EG 50 mg, comprimé quadrisécable
- Pharmaceutical form
- comprimé quadrisécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut-être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Hypertension artérielle<br>- Certaines pathologies rénales chez le patient diabètique insulino-dépendant<br>- Insuffisance cardiaque congestive <br>¿ Complications cardiaques suite à infarctus du myocarde chez les patients stabilisés uniquement, avec trouble fonctionnel du ventricule gauche et sans signe clinique d'insuffisance cardiaque ; JOURNAL OFFICIEL ; 11/08/06
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Dec 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68080825CIP73480383CIP133400934803833Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CAPTOPRILcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.